Julia Bradsher β€” investor profile photo

Julia Bradsher

BOARD DIRECTOR | CEO | LIFE SCIENCES | HEALTHCARE | STRATEGY | GROWTH | RISK

πŸ“ Los Angeles Metropolitan Area, United StatesπŸ”„ Updated November 2026πŸ’Ό 2 investmentsπŸ“… 14 years investingπŸ—“ Last invested Aug 2012𝕏 @upgrade_to_unlock
Angel investor🌍 United States
2
Total investments
1
Early stage
0
Mid stage
0
Late stage
14y
Years active

Portfolio

2 investments Β· sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Aug 2012
nanoRETE, Inc. is a Michigan-based company that is developing next generation technologies to provide real-time detection of pathogens and toxins using customized, proprietary nanoparticle biosensors. The Company’s approach is a major advancement from current technologies: a platform that has the ability to test for single or multiple pathogens/toxins (e.g., E. coli, Salmonella, Listeria, tuberculosis) using a simple-to-use portable device that can generate screening results in approximately 2-4 hours at a significantly lower cost than currently available approaches. Applications of the technology are targeted toward detection and subsequent protection in the commercial food industry along with military applications.
early stage
Board Member
Jan 2012
Portable Molecular Detection Instruments Rapid Detection of: Small Molecules (e.g., cortisol) Allergens and Toxins Antibodies, Antigens, and Nucleic Acids We provide instruments and reagent kits for applications where fast detection of small molecules, specific toxins, pathogens, allergens, or nucleic acid sequences are required. Applications include homeland security, environmental monitoring, medical diagnosis, and food safety. We also develop custom assays - contact us regarding your analyte of interest
Experience Β· 2 entries
All (2)
Investments (2)
Board (2)
2012
Board Member
Aug 2012
nanoRETE, Inc. is a Michigan-based company that is developing next generation technologies to provide real-time detection of pathogens and toxins using customized, proprietary nanoparticle biosensors. The Company’s approach is a major advancement from current technologies: a platform that has the ability to test for single or multiple pathogens/toxins (e.g., E. coli, Salmonella, Listeria, tuberculosis) using a simple-to-use portable device that can generate screening results in approximately 2-4 hours at a significantly lower cost than currently available approaches. Applications of the technology are targeted toward detection and subsequent protection in the commercial food industry along with military applications.
early stage
Board Member
Jan 2012
Portable Molecular Detection Instruments Rapid Detection of: Small Molecules (e.g., cortisol) Allergens and Toxins Antibodies, Antigens, and Nucleic Acids We provide instruments and reagent kits for applications where fast detection of small molecules, specific toxins, pathogens, allergens, or nucleic acid sequences are required. Applications include homeland security, environmental monitoring, medical diagnosis, and food safety. We also develop custom assays - contact us regarding your analyte of interest
Investor lists
Lists that match Julia's portfolio